Back to 
RA Capital Management, L.P.
RA Capital Management, L.P.
NAMS
Showing 8 of 15 quarters
Position history for RA Capital Management, L.P.'s holdings in NewAmsterdam Pharma Company N.V.
Yes. RA Capital Management holds 9,550,191 shares of NAMS (NewAmsterdam Pharma), worth $323.7M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. RA Capital Management has held NAMS since Q4 2022, across 15 quarterly 13F filings. NAMS is 2.8% of RA Capital Management's reported 13F portfolio.
Current Value
$323.7M
Current Shares
9.6M
Total Value Change
+$189.8M
Total Shares Change
+1.5M
Quarter-by-Quarter History